USFDA completes audit at Jubilant Pharmova’s step down subsidiary's facility

03 Aug 2022 Evaluate

United States Food and Drug Administration (USFDA) has concluded audit at Jubilant Pharmova’s step down subsidiary -- Jubilant Generics. The audit was conducted at Solid Dosage Formulations facility at Roorkee in Uttarakhand of Jubilant Generics. The USFDA has issued six observations pursuant to the completion of the audit. The company will submit an action plan on the observations and will engage with USFDA for next steps.

Jubilant Pharmova (formerly Jubilant Life Sciences) is a company engaged in pharmaceuticals, contract research and development services and proprietary novel drugs businesses.

Jubilant Pharmova Share Price

954.65 -13.60 (-1.40%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×